CBM
Cambrex Corporation
A drug-development partner for pharmaceutical and biotech companies, helping them research and manufacture the active ingredients and final drug products behind their medicines rather than selling its own branded drugs. Founded in 1981 under the name CasChem—short for castor chemicals, a nod to the castor-oil product lines it bought from NL Industries—the company changed its name to Cambrex in 1987 when it began trading on the NASDAQ.
CUSIP: 132011107HealthcareUS2 holders